Tag: kidney disease industry

  • Kidney Disease Market Overview 2024: Size, Growth Drivers, and Major Segments

    Kidney Disease Market Overview 2024: Size, Growth Drivers, and Major Segments

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Kidney Disease Market for the Period 2024 to 2033?

    Recently, the market size for kidney disease has experienced significant growth. The market which is projected to rise from $99.22 billion in 2023 to $106.6 billion in 2024, will experience a compound annual growth rate (CAGR) of 7.4%. The notable growth during the historic period is largely the result of increasing chronic health issues, an ageing population, genetic susceptibility, advancements in medical research and education, as well as environmental factors.

    In the upcoming years, the kidney disease market is projected to experience robust growth, expanding to $136.97 billion in 2028 with a compound annual growth rate (CAGR) of 6.5%. This expansion in the predicted timeframe can be credited to the global management of infectious diseases, precision medicine methods, the epidemic of diabetes and obesity, alterations in healthcare policies, and a significant increase in awareness and screening. Notably, the anticipated trends for this period encompass telemedicine for kidney health, an emphasis on preventive nephrology, a surge in home-based dialysis, development of regenerative treatments, and modifications in diet and nutrition.

    Claim Your Free Sample of the Global Kidney Disease Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=11938&type=smp

    What Factors Are Responsible for the Growth of the kidney disease Market?

    The kidney disease market’s expansion is anticipated to be fueled by the surging prevalence of kidney-related conditions. The term “kidney diseases” encompasses various disorders that hinder the kidneys’ functionality and structural integrity. Medications specifically targeting these disorders aim to decrease patients’ blood pressure, slow down kidney damage progression, handle symptoms, and avert complications by cutting down on protein loss. For instance, a UK-based charitable organization committed to enhancing understanding, prevention, and treatment of kidney diseases, Kidney Research UK, reported that as of June 2023, an estimated 7.19 million individuals in the UK carried a chronic kidney disease diagnosis, making up over 10% of the nation’s population. This figure is predicted to surge to 7.61 million by 2033. Consequently, this escalating prevalence of kidney diseases is propelling the kidney disease market’s growth.

    Which Segments Are Important for Insight into the Kidney Disease Market?

    1) By Treatment: Medication, Dialysis, Surgery, Other Treatments

    2) By Indication: Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indication

    3) By Route Of Administration: Oral, Parenteral

    4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users

    What Are the Significant Trends Reshaping the Kidney Disease Sector?

    The increasing usage of AI-enhanced tools is a prevailing trend gaining traction in the kidney disease sector. Firms operating in the kidney disease sector are embracing novel technologies for better patient outcomes and maintaining their market standing. In November 2022, for example, Carenostics, an American healthcare startup specializing in AI solutions, released its first product designed to examine electronic health record (EHR) data for the early detection of chronic kidney disease (CKD). Carenostics effectively incorporates AI-enhanced clinical decision support models into healthcare providers’ EHR systems, granting clinicians the power to precisely identify high-risk patients with chronic diseases. This allows them to take preemptive measures, leading to improved patient outcomes.

    Order Now for Fast Delivery of Your Kidney Disease Market Report!

    https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

    Which Regions Are Essential for the Growth of the Kidney Disease Market?

    North America was the largest region in the kidney disease market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Kidney Disease Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the kidney disease market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Kidney Disease Market Include

    1. Kidney Disease Market Executive Summary

    2. Kidney Disease Market Segments

    3. Kidney Disease Market Size And Template Market Growth Rate

    4. Key Kidney Disease Market Trends

    5. Major Kidney Disease Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Kidney Disease Market

    26. Top Kidney Disease Companies

    27. Kidney Disease Market Opportunities And Strategies

    28. Kidney Disease Market, Conclusions And Recommendations

    29. Appendix

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Overview Of The Kidney Disease Market 2024-2033: Growth And Major Players Analysis

    Overview Of The Kidney Disease Market 2024-2033: Growth And Major Players Analysis

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    Introduction:

    The kidney disease market has experienced significant growth in recent years, fueled by various factors such as rising chronic health conditions, an aging population, and increased awareness. This trend is poised to continue, driven by advancements in treatment modalities and evolving healthcare policies.

    Surging Incidence of Kidney Diseases Fuels Market Growth:

    • Kidney diseases affect millions globally, leading to increased demand for medications and treatments.
    • Chronic kidney disease (CKD) prevalence is projected to rise, emphasizing the need for effective management strategies.
    • Organizations like Kidney Research UK highlight the substantial burden of kidney diseases, indicating a growing patient population.

    The Rise of AI Integration in Healthcare with Carenostics Leading the Way:

    • Integration of AI-driven tools is revolutionizing kidney disease management.
    • Carenostics’ AI solutions leverage electronic health record (EHR) data for early CKD detection, enabling proactive patient care.
    • Such innovations empower healthcare providers to identify high-risk patients and tailor interventions accordingly.

    View More On The Kidney Disease Market Report 2024 – https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

    Acquisition of Cincor Pharma Inc. Expands Cardiorenal Portfolio for AstraZeneca:

    • Strategic acquisitions enhance companies’ capabilities in addressing kidney disease complexities.
    • AstraZeneca’s acquisition of CinCor Pharma Inc. expands its cardiorenal portfolio with baxdrostat (CIN-107), a promising compound for hypertension management in CKD patients.
    • This acquisition reflects a growing focus on comprehensive treatment approaches for kidney-related conditions.

    Segmentation of the Kidney Disease Market: The kidney disease market is segmented based on:

    1. Treatment: Medication, Dialysis, Surgery, and Other Treatments.
    2. Indication: Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, and Other Indications.
    3. Route of Administration: Oral, Parenteral.
    4. End-User: Hospitals, Diagnostic Laboratories, and Other End-Users.

    Regional Insights:

    • North America emerged as the largest region in the kidney disease market in 2023, driven by advanced healthcare infrastructure.
    • Europe is expected to witness rapid growth, attributed to increasing healthcare investments and a growing patient population.

    Future Outlook and Trends:

    • The kidney disease market is forecasted to reach $136.97 billion by 2028, propelled by global infectious disease management and precision medicine approaches.
    • Major trends include the integration of telemedicine for kidney care, emphasis on preventive nephrology, and the development of regenerative therapies.
    • Dietary modifications and nutrition interventions are gaining traction as complementary strategies in kidney disease management.

    Conclusion: The kidney disease market continues to evolve, driven by technological advancements, strategic acquisitions, and a growing understanding of disease mechanisms. With a focus on innovation and personalized care, stakeholders aim to address the complex needs of patients affected by kidney-related conditions, fostering improved outcomes and quality of life.

    Request A Sample Of The Global Kidney Disease Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=11938&type=smp